Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Corin Optimized Positioning System (OPS) Femoral

K-Number: K181061 · 2018-09-07

ApplicantCorin USA
Decision Date2018-09-07
Product CodeLZO
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Corin Optimized Positioning System (OPS) Femoral is a medical device manufactured by Corin USA. It received FDA 510(k) clearance on 2018-09-07 under approval number K181061. The device is classified under product code LZO. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Corin Optimized Positioning System (OPS) Femoral?

Corin Optimized Positioning System (OPS) Femoral is a medical device that received FDA 510(k) clearance on 2018-09-07. It is manufactured by Corin USA. The 510(k) number is K181061.

When was Corin Optimized Positioning System (OPS) Femoral approved by the FDA?

Corin Optimized Positioning System (OPS) Femoral received FDA 510(k) clearance on 2018-09-07, under approval number K181061.

What company makes Corin Optimized Positioning System (OPS) Femoral?

Corin Optimized Positioning System (OPS) Femoral is manufactured by Corin USA.

What is the FDA product code for Corin Optimized Positioning System (OPS) Femoral?

The FDA product code for Corin Optimized Positioning System (OPS) Femoral is LZO.

Related Clinical Trials

NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT01630707 Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy to Treat Patients With an Acute Heart Attack COMPLETED NCT07561372 Adaptive Recruitment Curve Analysis Using Bayesian Modeling NOT_YET_RECRUITING NCT06795763 Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures ENROLLING_BY_INVITATION NCT07594483 Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium NOT_YET_RECRUITING NCT07580651 Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring NOT_YET_RECRUITING

Other Devices by Corin USA

K152893Corin Optimized Positioning System (OPS) K152903REVIVAL(TM) Modular Revision Hip Stem K183038Corin Optimized Positioning System (OPS) Plan K190143LARS AC Band Device K190834Corin Optimized Position System Functional Hip Analysis (OPS FHA) K202805Optimized Positioning System (OPS) Insight

View all 12 devices →

Related Devices (Code: LZO)

K160895Initia Total Hip System & BIOCERAM AZUL(R) HEADKyocera Medical Corporation K161830Zimmer M/L Taper Hip ProsthesisZimmer, Inc. K161192Wagner SL Revision Stem Lateral, Wagner Cone Prosthesis® SystemZimmer GmbH K152893Corin Optimized Positioning System (OPS)Corin USA K160289MasterLoc StemMedacta International K152903REVIVAL(TM) Modular Revision Hip StemCorin USA

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑